Epieffect
EPIEFFECT is a lyophilised allograft membrane based on human placenta, including an amnion layer, an intermediate layer and a chorionic layer.
EPIEFFECT is intended for use as a barrier to provide a protective environment in acute and chronic wounds.
EPIEFFECT is intended for use as a barrier to provide a protective environment in acute and chronic wounds.
Benefits of Epieffect
Product benefits
- Easy to apply
- Stable on shelves*
- 5-year shelf life
- Finally sterilised for an extra level of safety
- Compatible with compression therapy, negative pressure wound therapy (NPWT) and hyperbaric oxygen therapy (HBOT)
- Contains more than 300 regulatory proteins1
*See instructions for use
- MIMEDX Internal Report. MM-RD-00101, Development of Lyophilized Human Amnion Chorion Membrane.
Examples of clinical use
The following clinical applications demonstrate the wide range of EPIEFFECT:
- Acute wounds
- Chronic wounds
- After the debridement
- Wounds removed
- Diabetic foot ulcers (DFU)
- Venous leg ulcers (VLU)
- Pressure ulcers (PU)
- Mohs repair
- Deep or tunnel wounds
